NICE issues recommendations on bisphosphonates for treating osteoporosis

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • National Institute for Health and Care Excellence (NICE) has issued evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis.

Key recommendations

  • In adults, oral bisphosphonates ...